Trends in surgical management of women with stress urinary incontinence (SUI) have changed in recent times, mainly due to the ‘High Vigilance Pause’ placed on the use of mesh for SUI (and prolapse) surgery in July 2018 following an independent...
MOWOOT II is an intermittent colonic exo-peristaltic therapy system for intestinal transit disorders, such as slow transit constipation. MOWOOT II utilises advanced pneumatic technology to treat and prevent chronic constipation without laxatives, enemas...
UroShield™ is a breakthrough disposable ultrasound device developed to prevent catheter blockages and biofilm formation, resulting in a reduction in Urinary Tract Infections (UTI) and therefore reducing the need for antibiotics, improving patient outcomes and lowering healthcare costs.
The rising cost of cancer care is a growing concern for health systems. A 2020 study estimated Europe’s annual cancer-related expenditure at €199 billion, with €109 billion attributed to healthcare costs. Bladder cancer (BC), in particular, imposes a significant financial...
Case 1 Name the machine shown in the picture and describe how it works. What is the standard frequency of ultrasound waves in this machine? What frequency of ultrasound waves are utilised in an abdominal and scrotal ultrasound? Case 2...
4 May 2020
| Robert Greenwood, Jonathan Charles Goddard
|
URO - Technology
The founding of the Royal Society of Medicine’s (RSM) Urology Section 100 years ago this year was crucial to the establishment of urology as a specialty in Great Britain in its own right. To mark this anniversary, earlier this year...
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). One of the most fascinating aspects of early Ancient Greek culture is the...
Keeping up to date with a variety of urology and medical journals can be an onerous task. Each year there is an ever-expanding number of medical journals and finding a way to sift through relevant information in medical journals and...
In this series of articles, I show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk) and in this one I am joined by Mary Garthwaite, retired urologist and Chair of The...
Active surveillance is a major treatment option for patients with favourable prognosis prostate cancer, such as those regarded as Cambridge Prognostic Group (CPG) 1 and 2 [1]. The rationale for this management strategy is the lack of survival benefit from...